Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
CareerCenter
Medical Coding Job Board
Log in Register free account

Need help choosing the right code?

Ask CasePilot about procedures, modifiers, bundling, and coding guidance.

Try CasePilot

Official Description

Antibody; Listeria monocytogenes

© Copyright 2026 American Medical Association. All rights reserved.

Common Language Description

The CPT® Code 86723 refers to a laboratory test specifically designed to measure antibodies against Listeria monocytogenes in both blood and cerebrospinal fluid (CSF). Listeria monocytogenes is a type of bacterium that is commonly found in various environments, including soil and water, and has the potential to contaminate food products such as raw fruits and vegetables, milk, and meat during their processing. This bacterium is notable for its ability to survive in refrigeration and freezing conditions, which poses a risk for foodborne illness. While L. monocytogenes typically causes mild gastrointestinal symptoms in healthy individuals, certain populations, including children, the elderly, and those with compromised immune systems, are at a heightened risk for more severe manifestations of the illness. Symptoms of listeriosis can include fever, muscle pain, nausea, diarrhea, headache, stiff neck, confusion, loss of balance, and seizures. Additionally, L. monocytogenes has the capability to cross the placenta, making pregnant women and their unborn children particularly susceptible to serious health complications. The testing process involves obtaining a blood sample through a separately reportable venipuncture and collecting CSF via a separately reportable lumbar puncture. The serum and CSF samples are then analyzed using a semi-quantitative complement fixation method to detect the presence of antibodies against the bacterium.

© Copyright 2026 Coding Ahead. All rights reserved.

1. Indications

The laboratory test coded as CPT® 86723 is indicated for the detection of antibodies to Listeria monocytogenes in patients who may be at risk for listeriosis. The following conditions and symptoms warrant the performance of this test:

  • Fever A common symptom that may indicate an underlying infection, particularly in vulnerable populations.
  • Muscle Pain Often associated with infections, muscle pain can be a sign of systemic illness.
  • Nausea This symptom may arise from gastrointestinal disturbances linked to L. monocytogenes infection.
  • Diarrhea A frequent symptom of gastrointestinal infections, which may be present in cases of listeriosis.
  • Headache Can occur in conjunction with other symptoms, particularly in cases of severe infection.
  • Stiff Neck This symptom may indicate meningitis, which can be caused by L. monocytogenes.
  • Confusion Neurological symptoms such as confusion may arise in severe cases of listeriosis.
  • Loss of Balance This can be a neurological sign associated with central nervous system involvement.
  • Seizures A serious symptom that may occur in severe cases of listeriosis affecting the central nervous system.
  • Pregnancy Pregnant women are particularly at risk due to the potential for the bacteria to cross the placenta, affecting both the mother and the fetus.

2. Procedure

The procedure for testing antibodies to Listeria monocytogenes involves several key steps, each critical for accurate diagnosis and assessment of potential infection. The first step is the collection of a blood sample, which is performed through a process known as venipuncture. This procedure involves inserting a needle into a vein, typically in the arm, to draw blood. It is important that this step is reported separately to ensure proper coding and billing. Following the blood collection, a lumbar puncture may be performed to obtain cerebrospinal fluid (CSF). This procedure involves inserting a needle into the lower back to access the spinal canal and collect CSF, which is also reported separately. Once both samples are collected, they are subjected to testing using a semi-quantitative complement fixation method. This laboratory technique allows for the detection and measurement of antibodies present in the serum and CSF, providing valuable information regarding the patient's immune response to Listeria monocytogenes.

3. Post-Procedure

After the completion of the antibody testing for Listeria monocytogenes, patients may be monitored for any immediate post-procedure effects, particularly following the lumbar puncture, which can sometimes lead to headaches or discomfort at the puncture site. It is essential for healthcare providers to provide appropriate post-procedure care instructions, which may include recommendations for hydration and rest. Patients should also be informed about potential symptoms to watch for, such as increased headache, fever, or any neurological changes, which may necessitate further medical evaluation. The results of the antibody tests will be interpreted by the healthcare provider, who will discuss the findings with the patient and determine any necessary follow-up actions based on the results and the patient's clinical presentation.

Short Descr LISTERIA MONOCYTOGENES
Medium Descr ANTIBODY LISTERIA MONOCYTOGENES
Long Descr Antibody; Listeria monocytogenes
Status Code Statutory Exclusion (from MPFS, may be paid under other methodologies)
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 9 - Not Applicable
Multiple Procedures (51) 9 - Concept does not apply.
Bilateral Surgery (50) 9 - Concept does not apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 9 - Concept does not apply.
Co-Surgeons (62) 9 - Concept does not apply.
Team Surgery (66) 9 - Concept does not apply.
Diagnostic Imaging Family 99 - Concept Does Not Apply
CLIA Waived (QW) No
APC Status Indicator Conditionally packaged laboratory tests
Type of Service (TOS) 5 - Diagnostic Laboratory
Berenson-Eggers TOS (BETOS) T1H - Lab tests - other (non-Medicare fee schedule)
MUE 2
CCS Clinical Classification 235 - Other Laboratory
90 Reference (outside) laboratory: when laboratory procedures are performed by a party other than the treating or reporting physician or other qualified health care professional, the procedure may be identified by adding modifier 90 to the usual procedure number.
Date
Action
Notes
2013-01-01 Changed Short Descriptor changed.
1993-01-01 Added First appearance in code book in 1993.
Code
Description
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"